SEC Form 4 · accession 0001209191-16-089905
ENTELLUS MEDICAL INC · ENTL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Karen E Peterson
Officer — SEE REMARKS
Period of report
Jan 4, 2016
Accepted (ET)
Jan 6, 2016 · 4:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001374128
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $16.99 | Jan 4, 2016 | A | 24,000 | A | — | Jan 4, 2026 | Common Stock | 24,000 | 24,000 | D |
Explanation of responses
- F1The option vests with respect to 1/48th of the shares beginning on February 4, 2016 (the first monthly anniversary of the vesting commencement date ("VCD")) and on each monthly anniversary of the VCD thereafter, subject to continued service through each applicable vesting date.
Remarks
The Reporting Person is Vice President, Clinical, Regulatory and Quality of the Issuer.